---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-027680"
form_type: "8-K"
ticker: "NXPL"
cik: "0001058307"
company_name: "NextPlat Corp"
filed_at: "2026-08-13T20:16:08+00:00"
generated_at: "2026-08-13T20:18:28.223030+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# NextPlat Q2 revenue up 21% sequentially to $11.9M; net loss down 87% to $144K

## Summary
- Q2 revenue $11.9M, +21% sequentially; gross margin record 40% vs 35% prior quarter.
- Net loss attributable to common stockholders $0.1M ($0.05/diluted share) vs $1.8M ($0.69) year ago.
- Contracted pharmacy revenue up 136% YoY to $2.2M; e-commerce revenue $4.1M, +27% sequentially.
- Cash $11.9M, working capital $14.2M, no material unsecured debt; 11 new contracted entities signed in H1.
- Intends to acquire profitable pharmacy operation in Pensacola, FL; new nationwide medication fulfillment website expected Q3.

## SEC filing metadata
- accession: 0001437749-26-027680
- form_type: 8-K
- ticker: NXPL
- cik: 0001058307
- company_name: NextPlat Corp
- filed_at: 2026-08-13T20:16:08+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1058307/000143774926027680/0001437749-26-027680-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1058307/000143774926027680/nxpl20260526_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-027680
- JSON: https://secwatch.observer/filing/0001437749-26-027680.json
- Plain text: https://secwatch.observer/filing/0001437749-26-027680.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.